Differential beta-adrenoblocker therapy in chronic heart failure: the role of age, gender, and co-morbidity
Aim. To investigate differential beta-adrenoblocker (BAB) therapy, based on clinical and demographic characteristics of the patients, as a method to optimise the management of chronic heart failure (CHF).Material and methods. The study included 90 patients: 50 men (55,6%) and 40 women (44,4%) of mea...
Saved in:
| Main Authors: | S. N. Tereshchenko, I. V. Zhirov, A. V. Akinina, A. G. Kochetov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2009-10-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1855 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Differential beta-adrenoblocker therapy in chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (1970-01-01) -
Differential approach in selecting beta-adrenoblocker therapy for patients with chronic heart failure and anaemia
by: T. M. Uskach, et al.
Published: (2012-04-01) -
Beta-adrenoblocker in heart failure: bisoprolol role
by: Yu. V. Lukina, et al.
Published: (1970-01-01) -
Intravenous beta-adrenoblocker therapy in acute coronary syndrome patients
by: S. N. Tereshchenko, et al.
Published: (1970-01-01) -
URODYNAMIC EFFECTS OF BETA-ADRENOBLOCKERS: NEBIVOLOL ADVANTAGES
by: M. P. Savenkov, et al.
Published: (2016-01-01)